| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |